cycloastragenol has been researched along with beta-escin in 12 studies
| Studies (cycloastragenol) | Trials (cycloastragenol) | Recent Studies (post-2010) (cycloastragenol) | Studies (beta-escin) | Trials (beta-escin) | Recent Studies (post-2010) (beta-escin) |
|---|---|---|---|---|---|
| 62 | 0 | 55 | 14,137 | 211 | 6,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| He, K; Wang, HK | 1 |
| Chen, YS; Ruan, M; Yu, B; Zhang, LY; Zhuang, Y | 1 |
| Chin, AC; Harley, CB; Ho, MK; Hu, Y; Ip, FC; Ip, NY; Lam, WS; Pang, H; Wong, YH; Yung, LY | 1 |
| Ruan, JQ; Song, YL; Wang, YT; Yan, R; Zhou, RN | 1 |
| Cao, J; Feng, LM; Guo, DA; Huang, FX; Lin, XH; Qiao, X; Ye, M | 1 |
| Agra, LC; Barbosa, FT; Barreto, E; Ferro, JN | 1 |
| Li, J; Li, Q; Liu, B; Liu, K; Sun, Y; Zhang, N; Zhao, W; Zhao, Y | 1 |
| Chao, L; Han, L; Li, X; Ruan, J; Shi, P; Wang, T; Zhang, Y | 1 |
| Chen, Y; Wang, L | 1 |
| Qi, R; Tuerdi, N; Wan, Y; Wang, Y; Xu, L; Ye, M | 1 |
| Ahmad, S; Choe, K; Ikram, M; Jo, MH; Khan, A; Kim, MO; Kim, MW; Saeed, K | 1 |
| Fukami, H; Kishino, S; Ogawa, J; Ozeki, Y; Takeuchi, DM | 1 |
2 review(s) available for cycloastragenol and beta-escin
| Article | Year |
|---|---|
[Recent development of chemical studies on some medicinal plants of Astragalus spp].
Topics: Chemical Phenomena; Chemistry; Drugs, Chinese Herbal; Glucosides; Glycosides; Sapogenins; Saponins; Triterpenes | 1988 |
Triterpenes with healing activity: A systematic review.
Topics: Cell Movement; Cell Proliferation; Collagen; Fibroblasts; Ginsenosides; Humans; Keratinocytes; Pentacyclic Triterpenes; Reactive Oxygen Species; Sapogenins; Saponins; Skin; Skin Diseases; Triterpenes; Ursolic Acid; Wound Healing | 2015 |
10 other study(ies) available for cycloastragenol and beta-escin
| Article | Year |
|---|---|
[Transformation of astragaloside IV in bidirectional solid fermenting of Astragalus membranaceus].
Topics: Antioxidants; Astragalus propinquus; Chromatography, High Pressure Liquid; Fermentation; Ganoderma; Molecular Structure; Plant Roots; Plants, Medicinal; Sapogenins; Saponins; Triterpenes | 2010 |
Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types.
Topics: Astragalus Plant; Brain; Breast; Cell Line; Dose-Response Relationship, Drug; Endothelial Cells; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Humans; Lung; Phosphorylation; Plant Extracts; Sapogenins; Saponins; src-Family Kinases; Telomerase; Triterpenes | 2012 |
Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of astragaloside IV, a marker compound of astragali radix, in traditional oral use of the herb.
Topics: Administration, Oral; Animals; Area Under Curve; Bacteria; Biotransformation; Drugs, Chinese Herbal; Feces; Intestinal Mucosa; Intestines; Male; Rats; Rats, Sprague-Dawley; Sapogenins; Saponins; Triterpenes | 2012 |
Smith degradation, an efficient method for the preparation of cycloastragenol from astragaloside IV.
Topics: Acids; Astragalus propinquus; Chromatography, Liquid; Drugs, Chinese Herbal; Hydrolysis; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Oxidation-Reduction; Sapogenins; Saponins; Triterpenes | 2014 |
Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium.
Topics: Apoptosis; Carrier Proteins; Caspase 3; Cells, Cultured; Endoplasmic Reticulum Stress; Endoribonucleases; Endothelial Cells; Humans; Inflammasomes; Membrane Potential, Mitochondrial; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Sapogenins; Saponins; Triterpenes | 2015 |
Bioactive cyclolanstane-type saponins from the stems of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao.
Topics: Astragalus propinquus; Hep G2 Cells; Humans; Hypolipidemic Agents; Plant Extracts; Plant Stems; Sapogenins; Saponins; Triglycerides | 2016 |
Efficient Biotransformation of Astragaloside IV to Cycloastragenol by Bacillus sp. LG-502.
Topics: Bacillus; Biotransformation; Magnetic Resonance Spectroscopy; Mass Spectrometry; Sapogenins; Saponins; Triterpenes | 2017 |
Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome.
Topics: Animals; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Fibroblasts; Fibrosis; Heart; Humans; Inflammasomes; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sapogenins; Saponins; Triterpenes | 2018 |
Cycloastragenol, a Triterpenoid Saponin, Regulates Oxidative Stress, Neurotrophic Dysfunctions, Neuroinflammation and Apoptotic Cell Death in Neurodegenerative Conditions.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; Brain; Cyclic AMP Response Element-Binding Protein; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Inflammation; Inflammation Mediators; Memory Disorders; Mice, Inbred C57BL; Microglia; Nerve Growth Factors; Nerve Tissue Proteins; Neurodegenerative Diseases; Oxidative Stress; Phosphorylation; Sapogenins; Saponins; Triterpenes | 2021 |
Analysis of astragaloside IV metabolism to cycloastragenol in human gut microorganism, bifidobacteria, and lactic acid bacteria.
Topics: Bacteria; Bifidobacterium; Glucose; Humans; Lactobacillales; Sapogenins; Saponins; Triterpenes; Xylose | 2022 |